Follow
Lung cancer screening
Lung cancer screening involves testing for lung cancer when no symptoms or disease history exist in an effort to increase early diagnosis, where treatments are more effective. The US Preventive Services Task Force recommends yearly lung cancer screening for individuals aged 50 - 80 who have a history of smoking 20 or more packs of cigarettes/year and currently smoke or quit smoking in the past 15 years. Screening is done via a non-invasive low-dose CT scan (LDCT) which uses a low dose of radiation to X-ray image the lungs.
JUN 02, 2022 | 8:30 AM
Date: June 02, 2022 Time: 8:30am (PST), 10:30am (CST), 11:30am (EST) Cardiac biomarkers like high-sensitivity Troponin I might play a major role in the prevention of cardiovascular diseases....
SEP 29, 2021 | 11:00 AM
Date: Septembr 29, 2021 Time: 11:00am (PDT), 2:00pm (EDT) 3D cell models are becoming increasingly popular for studying complex biological effects, tissue functionality, and diseases. While...
MAY 27, 2021 | 9:00 AM
Date: May 27, 2021 Time: 9:00am PDT Since the current SARS-CoV-2 outbreak, there has been an urgent need to define the immune response and understand the relevant immunological mechanisms un...
FEB 10, 2021 | 12:00 AM
Key to the development of the HUB Organoid Technology was the discovery of LGR5+ intestinal adult stem cells by the Clevers’ lab. With the identification of these stem cells, we were a...
DEC 03, 2020 | 4:30 PM
This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
OCT 08, 2020 | 10:00 AM
DATE: October 8, 2020 TIME: 1:00pm PDT Microsatellite instability (MSI) has evolved as a marker of potential hereditary cancer risk and is now a tissue agnostic immune biomarker with a broad...
SEP 30, 2020 | 12:00 AM
Combinatorial inhibition of effector and feedback pathways is a promising treatment strategy for KRAS mutant cancers. However, the particular pathways that should be targeted to optimize the...
JUN 18, 2020 | 9:00 AM
DATE: June 18, 2020 TIME: 9:00am PDT, 12:00pm EDT Despite the success of immunotherapy against several malignancies including melanoma and lung adenocarcinoma, glioblastoma remains the excep...
APR 24, 2020 | 8:00 AM
The International Council for Standardization in Haematology (ICSH) is a nonprofit organization dedicated to providing open-access guidance documents to enhance the quality of laboratory tes...
APR 22, 2020 | 8:00 AM
Rapid access to high quality comprehensive coagulation test results is critical to patient care. In an environment where clinical laboratories constantly experience price and labor pressure,...
APR 20, 2020 | 8:00 AM
This talk will cover different approaches to emergency hemostasis testing for patients that are actively bleeding due to trauma, surgery, obstetrical emergencies and other causes. The talk i...
